[1] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA: a cancer journal for clinicians 61 (2):69-90
[2] Lopez-Soto A, Folgueras AR (2018) Cancer Immunosurveillance. Springer,
[3] Beatty GL, Gladney WL (2015) Immune escape mechanisms as a guide for cancer immunotherapy. Clinical cancer research 21 (4):687-692
[4] Guillerey C, Huntington ND, Smyth MJ (2016) Targeting natural killer cells in cancer immunotherapy. Nature immunology 17 (9):1025
[5] Gajewski TF, Schreiber H, Fu Y-X (2013) Innate and adaptive immune cells in the tumor microenvironment. Nature immunology 14 (10):1014
[6] Liu C, Workman CJ, Vignali DA (2016) Targeting regulatory T cells in tumors. The FEBS journal 283 (14):2731-2748
[7] Abedi-Valugerdi M, Wolfsberger J, Pillai PR, Zheng W, Sadeghi B, Zhao Y, Hassan M (2016) Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice. International immunopharmacology 40:41-49
[8] Nowak AK, Robinson BW, Lake RA (2002) Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer research 62 (8):2353-2358
[9] Pretto F, Elia G, Castioni N, Neri D (2014) Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy. Cancer Immunology, Immunotherapy 63 (9):901-910
[10] Tobin RP, Davis D, Jordan KR, McCarter MD (2007) The clinical evidence for targeting human myeloid‐derived suppressor cells in cancer patients. Journal of leukocyte biology 102 (2):381-391
[11] Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F (2012) Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148 (1-2):362-375
[12] Andasari V, Gerisch A, Lolas G, South AP, Chaplain MA (2011) Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation. Journal of mathematical biology 63 (1):141-171
[13] Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature medicine 7 (6):673
[14] Wu Y, Giger ML, Doi K, Vyborny CJ, Schmidt RA, Metz CE (1993) Artificial neural networks in mammography: application to decision making in the diagnosis of breast cancer. Radiology 187 (1):81-87
[15] Byrne H, Alarcon T, Owen M, Webb S, Maini P (2006) Modelling aspects of cancer dynamics: a review. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 3 64 (1843): 1563-1578
[16] Friedman A (2004) A hierarchy of cancer models and their mathematical challenges. Discrete and Continuous Dynamical Systems Series B 4 (1):147-160
[17] Eftimie R, Bramson JL, Earn DJ (2011) Interactions between the immune system and cancer: a brief review of non-spatial mathematical models. Bulletin of mathematical biology 73 (1):2-32
[18] Bose T, Trimper S (2009) Stochastic model for tumor growth with immunization. Physical Review E 79 (5):051903
[19] Kim KS, Kim S, Jung IH (2016) Dynamics of tumor virotherapy: A deterministic and stochastic model approach. Stochastic Analysis and Applications 34 (3):483-495
[20] Murphy H, Jaafari H, Dobrovolny HM (2016) Differences in predictions of ODE models of tumor growth: a cautionary example. BMC cancer 16 (1):163
[21] Mallet DG, De Pillis LG (2006) A cellular automata model of tumor–immune system interactions. Journal of theoretical biology 239 (3):334-350
[22] Fumia HF, Martins ML (2013) Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes. PloS one 8 (7):e69008
[23] Minervini G, Panizzoni E, Giollo M, Masiero A, Ferrari C, Tosatto SC (2014) Design and analysis of a Petri net model of the Von Hippel-Lindau (VHL) tumor suppressor interaction network. PloS one 9 (6):e96986
[24] Albano G, Giorno V (2006) A stochastic model in tumor growth. Journal of Theoretical Biology 242 (2):329-336
[25] Terragni F, Carretero M, Capasso V, Bonilla L (2016) Stochastic model of tumor-induced angiogenesis: ensemble averages and deterministic equations. Physical Review E 93 (2):022413
[26] Baar M, Coquille L, Mayer H, Hölzel M, Rogava M, Tüting T, Bovier A (2016) A stochastic model for immunotherapy of cancer. Scientific reports 6:24169
[27] Park SY, Sargent D Tumor propagation model using generalized hidden Markov model. In: Medical Imaging 2017: Image Processing, 2017. International Society for Optics and Photonics, p 101331G
[28] Trairatphisan P, Wiesinger M, Bahlawane C, Haan S, Sauter T (2016) A Probabilistic Boolean network approach for the analysis of cancer-specific signalling: a case study of deregulated pdgf signalling in GIST. PloS one 11 (5):e0156223
[29] Gong C, Milberg O, Wang B, Vicini P, Narwal R, Roskos L, Popel AS (2017) A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition. Journal of The Royal Society Interface 14 (134):20170320
[30] Interian R, Rodríguez-Ramos R, Valdés-Ravelo F, Ramirez-Torres A, Ribeiro C, Conci A (2017) Tumor growth modelling by cellular automata. Mathematics and Mechanics of Complex Systems 5 (3):239-259
[31] Zupanc GK, Zupanc FB, Sipahi R (2019) Stochastic cellular automata model of tumorous neurosphere growth: Roles of developmental maturity and cell death. Journal of theoretical biology 467:100-110
[32] Shafiekhani S, Rahbar S, Akbarian F, Hadjati J, Allahverdy A, Jafari AH (2017) Providing a Stochastic Petri Net Model for Interactions of the Immune System and B16-F10 Tumor Cells in order to Investigate the Effect of Myeloid-Derived Suppressor Cells (MDSC) on Behavioral States of Tumor. Frontiers in Biomedical Technologies 4 (1-2):31-37
[33] Figueredo GP, Siebers P-O, Aickelin U Investigating mathematical models of immuno-interactions with early-stage cancer under an agent-based modelling perspective. In: BMC bioinformatics, 2013. vol 6. BioMed Central, p S6
[34] Wilson S, Levy D (2012) A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy. Bulletin of mathematical biology 74 (7):1485-1500
[35] Brown JS, Cunningham JJ, Gatenby RA (2017) Aggregation effects and population-based dynamics as a source of therapy resistance in cancer. IEEE Transactions on Biomedical Engineering 64 (3):512-518
[36] Paul R, Das MA, Bhattacharya D, Sarmah HK (2019) A Policy to Eradicate Tumor in a Discrete-Continuous Immune Cell-Tumor Cell-Drug Administration Model with the Help of Stability Analysis and Bifurcation Analysis of the Model. International Journal of Applied Engineering Research 14 (9):2192-2197
[37] Wilkie KP, Hahnfeldt P (2017) Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation. Bulletin of mathematical biology 79 (6):1426-1448
[38] Shariatpanahi SP, Shariatpanahi SP, Madjidzadeh K, Hassan M, Abedi-Valugerdi M (2018) Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies. Journal of theoretical biology 442:1-10
[39] Zadeh LA (1965) Fuzzy sets. Information and control 8 (3):338-353
[40] Liu F, Heiner M, Yang M (2016) Fuzzy stochastic petri nets for modeling biological systems with uncertain kinetic parameters. PloS one 11 (2):e0149674
[41] Liu F, Chen S, Heiner M, Song H (2018) Modeling biological systems with uncertain kinetic data using fuzzy continuous Petri nets. BMC systems biology 12 (4):42
[42] Park I, Na D, Lee D, Lee KH (2005) Fuzzy continuous Petri Net-based approach for modeling immune systems. In: Neural Nets. Springer, pp 278-285
[43] Marino S, Hogue IB, Ray CJ, Kirschner DE (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. Journal of theoretical biology 254 (1):178-196